ConductScience.org, home

Paper2822019

Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.

Hue L and 1 other. Biochem J, 1987. Cited by 366 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Papers, record 2822019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2822019

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.
PubMed
Journal
Biochem J
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
366
iCite
Relative citation ratio, by iCite
8.76
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hue LL
2Rider MHM H

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FructosediphosphatesMajor topic
GlycolysisMajor topic
HexosediphosphatesMajor topic
MammalsMajor topic
Animals
Liver
Phosphofructokinase-2
Phosphoric Monoester Hydrolases
Phosphorylation
Tissue Distribution

Source PubMed

References166

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,688,419The interaction of fructose 2,6-bisphosphate and AMP with rat hepatic fructose 1,6-bisphosphatase.J Biol Chem1983https://conductscience.org/library/papers/6688419PubMed
26,260,770Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate.J Biol Chem1981https://conductscience.org/library/papers/6260770PubMed
36,453,589Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase.Biochem J1980https://conductscience.org/library/papers/6453589PubMed
4319,362Enzymology of cancer cells (first of two parts).N Engl J Med1977https://conductscience.org/library/papers/319362PubMed
53,021,137Effect of tolbutamide on fructose-6-phosphate,2-kinase and fructose-2,6-bisphosphatase in rat liver.Biochem Biophys Res Commun1986https://conductscience.org/library/papers/3021137PubMed
66,092,364Effect of sulfhydryl modification on the activities of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.J Biol Chem1984https://conductscience.org/library/papers/6092364PubMed
72,997,199Fructose-1,6-bisphosphatase from rat liver. A comparison of the kinetics of the unphosphorylated enzyme and the enzyme phosphorylated by cyclic AMP-dependent protein kinase.J Biol Chem1985https://conductscience.org/library/papers/2997199PubMed
84,830,198A linear steady-state treatment of enzymatic chains. General properties, control and effector strength.Eur J Biochem1974https://conductscience.org/library/papers/4830198PubMed
96,392,338The glucose paradox. Is glucose a substrate for liver metabolism?J Clin Invest1984https://conductscience.org/library/papers/6392338PubMed
103,010,981Effects of diabetes on fructose 2, 6-P2, glucose 1, 6-P2 and 6-phosphofructo 2-kinase in rat liver.Biochem Biophys Res Commun1986https://conductscience.org/library/papers/3010981PubMed
116,096,384Rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase: a review of relationships between the two activities of the enzyme.J Cell Biochem1984https://conductscience.org/library/papers/6096384PubMed
126,311,081Gluconeogenesis and related aspects of glycolysis.Annu Rev Biochem1983https://conductscience.org/library/papers/6311081PubMed
136,453,588Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase.Biochem J1980https://conductscience.org/library/papers/6453588PubMed
14153,704Phosphofructokinase.Adv Enzymol Relat Areas Mol Biol1979https://conductscience.org/library/papers/153704PubMed
156,092,081The protein phosphatases involved in cellular regulation. Glycolysis, gluconeogenesis and aromatic amino acid breakdown in rat liver.Eur J Biochem1984https://conductscience.org/library/papers/6092081PubMed
166,301,824The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities.Eur J Biochem1983https://conductscience.org/library/papers/6301824PubMed
173,004,827Fructose 2,6-bisphosphate and enzymatic activities for its metabolism in ascites tumor.Curr Top Cell Regul1985https://conductscience.org/library/papers/3004827PubMed
186,688,179Perinatal changes of fructose 2,6-bisphosphate in the rat liver.Biochem Biophys Res Commun1983https://conductscience.org/library/papers/6688179PubMed
193,019,688Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle.Eur J Biochem1986https://conductscience.org/library/papers/3019688PubMed
206,451,625Fructose 2,6-bisphosphate. A new activator of phosphofructokinase.J Biol Chem1981https://conductscience.org/library/papers/6451625PubMed

See all 166 references

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 366 citations.

PMIDTitleJournalYearIn PapersSource
42,751,120Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights.Genes Dis2027https://conductscience.org/library/papers/42751120PubMed
40,454,774Neural Metabolic Networks: Key Elements of Healthy Brain Function.J Neurochem2025https://conductscience.org/library/papers/40454774PubMed
39,318,551Pathogenic role of PFKFB3 in endothelial inflammatory diseases.Front Mol Biosci2024https://conductscience.org/library/papers/39318551PubMed
38,964,783Genetically engineering glycolysis in T cells increases their antitumor function.J Immunother Cancer2024https://conductscience.org/library/papers/38964783PubMed
38,206,915Ameliorating the impairment of glucose utilization in a high-fat diet-induced obesity model through the consumption of Tucum-do-Cerrado (Bactris Setosa Mart.).PLoS One2024https://conductscience.org/library/papers/38206915PubMed
37,958,470PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities.Cancers (Basel)2023https://conductscience.org/library/papers/37958470PubMed
37,534,142Increased cardiac PFK-2 protects against high-fat diet-induced cardiomyopathy and mediates beneficial systemic metabolic effects.iScience2023https://conductscience.org/library/papers/37534142PubMed
36,712,976Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/36712976PubMed
36,625,925Autologous blood transfusion impedes glycolysis in macrophages to inhibit red blood cell injury in type 2 diabetes through PI3K/Akt/PKM2 signaling axis.Acta Diabetol2023https://conductscience.org/library/papers/36625925PubMed
35,879,299Beyond controlling cell size: functional analyses of S6K in tumorigenesis.Cell Death Dis2022https://conductscience.org/library/papers/35879299PubMed
35,289,743Octopamine drives honeybee thermogenesis.Elife2022https://conductscience.org/library/papers/35289743PubMed
35,140,684Identification of Key LncRNAs and Pathways in Prediabetes and Type 2 Diabetes Mellitus for Hypertriglyceridemia Patients Based on Weighted Gene Co-Expression Network Analysis.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/35140684PubMed
35,056,904Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.Pharmaceutics2021https://conductscience.org/library/papers/35056904PubMed
33,673,114Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.J Clin Med2021https://conductscience.org/library/papers/33673114PubMed
32,911,833Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer's Disease.Cells2020https://conductscience.org/library/papers/32911833PubMed
31,991,105Metabolic Control over mTOR-Dependent Diapause-like State.Dev Cell2020https://conductscience.org/library/papers/31991105PubMed
31,686,003The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.Nat Rev Cancer2020https://conductscience.org/library/papers/31686003PubMed
31,413,316Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression.Nat Commun2019https://conductscience.org/library/papers/31413316PubMed
31,308,477Inferring novel genes related to colorectal cancer via random walk with restart algorithm.Gene Ther2019https://conductscience.org/library/papers/31308477PubMed
31,185,774Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.J Am Heart Assoc2019https://conductscience.org/library/papers/31185774PubMed

See all 104 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2822019

GET https://conductscience.org/api/papers/v1/2822019/references?page=2